BG106699A - Нови тиазолидиндионови производни като противодиабетични средства - Google Patents

Нови тиазолидиндионови производни като противодиабетични средства Download PDF

Info

Publication number
BG106699A
BG106699A BG106699A BG10669902A BG106699A BG 106699 A BG106699 A BG 106699A BG 106699 A BG106699 A BG 106699A BG 10669902 A BG10669902 A BG 10669902A BG 106699 A BG106699 A BG 106699A
Authority
BG
Bulgaria
Prior art keywords
ethoxy
benzyl
thiazolidine
dione
compound
Prior art date
Application number
BG106699A
Other languages
Bulgarian (bg)
English (en)
Inventor
Mancini Marisabel Mourelle
Ramon Amat Elisabet De
CASTILLO NIETO Juan DEL
Original Assignee
Laboratorios Vita,S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Vita,S.A. filed Critical Laboratorios Vita,S.A.
Publication of BG106699A publication Critical patent/BG106699A/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BG106699A 1999-11-18 2002-05-14 Нови тиазолидиндионови производни като противодиабетични средства BG106699A (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES009902533A ES2156574B1 (es) 1999-11-18 1999-11-18 Nuevos derivados de tiazolidindiona como agentes antidiabeticos
PCT/ES2000/000432 WO2001036416A1 (es) 1999-11-18 2000-11-15 Nuevos derivados de tiazolidindiona como agentes antidiabeticos

Publications (1)

Publication Number Publication Date
BG106699A true BG106699A (bg) 2003-02-28

Family

ID=8310628

Family Applications (1)

Application Number Title Priority Date Filing Date
BG106699A BG106699A (bg) 1999-11-18 2002-05-14 Нови тиазолидиндионови производни като противодиабетични средства

Country Status (37)

Country Link
US (1) US7001910B1 (zh)
EP (1) EP1231211B1 (zh)
JP (1) JP2003514817A (zh)
KR (1) KR100518110B1 (zh)
CN (1) CN1159314C (zh)
AP (1) AP1330A (zh)
AR (1) AR031080A1 (zh)
AT (1) ATE241622T1 (zh)
AU (1) AU770045B2 (zh)
BG (1) BG106699A (zh)
BR (1) BR0015613A (zh)
CA (1) CA2391913A1 (zh)
CO (1) CO5261560A1 (zh)
CR (1) CR6640A (zh)
CZ (1) CZ20021654A3 (zh)
DE (1) DE60003072T2 (zh)
DK (1) DK1231211T3 (zh)
EA (1) EA004301B1 (zh)
EE (1) EE200200254A (zh)
ES (2) ES2156574B1 (zh)
GE (1) GEP20043240B (zh)
HR (1) HRP20020426A2 (zh)
HU (1) HUP0203478A2 (zh)
IL (1) IL149634A0 (zh)
IS (1) IS2014B (zh)
MA (1) MA26844A1 (zh)
MX (1) MXPA02005011A (zh)
NO (2) NO20022336L (zh)
NZ (1) NZ519264A (zh)
OA (1) OA12089A (zh)
PE (1) PE20010858A1 (zh)
PL (1) PL354877A1 (zh)
PT (1) PT1231211E (zh)
SK (1) SK6752002A3 (zh)
WO (1) WO2001036416A1 (zh)
YU (1) YU40202A (zh)
ZA (1) ZA200203906B (zh)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2174748B1 (es) * 2001-01-31 2003-09-16 Vita Lab Nueva sal de tiazolidindiona y sus polimorfos como agentes antidiabeticos y procedimiento para la obtencion de los mismos.
KR100450700B1 (ko) * 2002-03-22 2004-10-01 주식회사종근당 티아졸리딘디온 유도체 화합물 및 이를 함유하는 약제학적조성물
CL2004000409A1 (es) 2003-03-03 2005-01-07 Vertex Pharma Compuestos derivados de 2-(cilo sustituido)-1-(amino u oxi sustituido)-quinazolina, inhibidores de canales ionicos de sodio y calcio dependientes de voltaje; composicion farmaceutica; y uso del compuesto en el tratamiento de dolor agudo, cronico, neu
US7713983B2 (en) 2003-03-03 2010-05-11 Vertex Pharmaceuticals Incorporated Quinazolines useful as modulators of ion channels
US20050014732A1 (en) * 2003-03-14 2005-01-20 Pharmacia Corporation Combination of an aldosterone receptor antagonist and an anti-diabetic agent
US7928107B2 (en) 2004-09-02 2011-04-19 Vertex Pharmaceuticals Incorporated Quinazolines useful as modulators of ion channels
US8283354B2 (en) 2004-09-02 2012-10-09 Vertex Pharmaceuticals Incorporated Quinazolines useful as modulators of ion channels
CZ297347B6 (cs) * 2004-09-21 2006-11-15 Zentiva, A. S. Zpusob prípravy rosiglitazonu
JP5546372B2 (ja) * 2010-06-30 2014-07-09 積水メディカル株式会社 ベンジルヒダントイン化合物の製造法
WO2016184895A1 (en) 2015-05-18 2016-11-24 Institut National De La Sante Et De La Recherche Medicale (Inserm) Means for detecting or measuring a biological activity of a botulinum toxin
US10689374B1 (en) 2019-07-12 2020-06-23 United Arab Emirates University Pyrimidine-thiazolidinone derivatives
US10702525B1 (en) 2019-09-04 2020-07-07 United Arab Emirates University Pyrimidine derivatives as anti-diabetic agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR240698A1 (es) * 1985-01-19 1990-09-28 Takeda Chemical Industries Ltd Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales
ATE186724T1 (de) * 1987-09-04 1999-12-15 Beecham Group Plc Substituierte thiazolidindionderivate
GB9023583D0 (en) * 1990-10-30 1990-12-12 Beecham Group Plc Novel compounds

Also Published As

Publication number Publication date
EA200200470A1 (ru) 2002-10-31
ZA200203906B (en) 2004-03-26
NZ519264A (en) 2003-10-31
BR0015613A (pt) 2002-07-23
HUP0203478A2 (hu) 2003-02-28
ATE241622T1 (de) 2003-06-15
AU1281501A (en) 2001-05-30
YU40202A (sh) 2006-01-16
MA26844A1 (fr) 2004-12-20
ES2156574A1 (es) 2001-06-16
AR031080A1 (es) 2003-09-10
CN1159314C (zh) 2004-07-28
DE60003072D1 (de) 2003-07-03
US7001910B1 (en) 2006-02-21
SK6752002A3 (en) 2002-09-10
CZ20021654A3 (cs) 2002-09-11
ES2156574B1 (es) 2002-02-01
IS6386A (is) 2002-05-15
PE20010858A1 (es) 2001-08-22
CO5261560A1 (es) 2003-03-31
NO20022379D0 (no) 2002-05-16
NO20022336D0 (no) 2002-05-15
PT1231211E (pt) 2003-09-30
CA2391913A1 (en) 2001-05-25
IS2014B (is) 2005-06-15
EP1231211B1 (en) 2003-05-28
HRP20020426A2 (en) 2004-02-29
GEP20043240B (en) 2004-05-25
EE200200254A (et) 2003-06-16
ES2199878T3 (es) 2004-03-01
AP1330A (en) 2004-11-25
AP2002002512A0 (en) 2002-06-30
CR6640A (es) 2004-03-05
MXPA02005011A (es) 2003-10-14
CN1402724A (zh) 2003-03-12
JP2003514817A (ja) 2003-04-22
OA12089A (en) 2006-05-04
EP1231211A1 (en) 2002-08-14
EA004301B1 (ru) 2004-02-26
WO2001036416A1 (es) 2001-05-25
KR20020079737A (ko) 2002-10-19
NO20022336L (no) 2002-07-09
DE60003072T2 (de) 2004-04-01
KR100518110B1 (ko) 2005-10-04
AU770045B2 (en) 2004-02-12
DK1231211T3 (da) 2003-10-27
PL354877A1 (en) 2004-03-08
IL149634A0 (en) 2002-11-10

Similar Documents

Publication Publication Date Title
EP1567112B1 (en) THIAZOLIDIN-4-ONES FOR INHIBITING hYAK3 PROTEINS
JP5302540B2 (ja) プロテインキナーゼ阻害剤として有用な２，５及び２，６−二置換ベンザゾール類似体
US20070021446A1 (en) 2-arylbenzothiazole analogues and uses thereof
US20040229876A1 (en) Quinoline derivatives and quinazoline derivatives having azolyl group
BG106699A (bg) Нови тиазолидиндионови производни като противодиабетични средства
NZ226027A (en) N-substituted amino ethoxy benzylidene-2,4-thiazolidinedione derivatives and pharmaceutical compositions
JP2000001487A (ja) 縮合複素環誘導体
US20070249599A1 (en) Novel Chemical Compounds
TW420669B (en) Pyridine type thiazolidines
US7576090B2 (en) Benzazole analogues and uses thereof
US4824833A (en) Benzoxazine derivatives
EP0787725B1 (en) Quinoline derivative
KR100450700B1 (ko) 티아졸리딘디온 유도체 화합물 및 이를 함유하는 약제학적조성물
JP2009501164A (ja) ２−アリールベンゾチアゾール及びその使用
US20040023977A1 (en) Process for making substituted thiazolyl-amino pyrimidinyl